HOTH Q2 2018 Earnings — Hoth Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOTHHoth Therapeutics, Inc.

$15M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$763,420

Net Income

-$763,420

EPS (Diluted)

$-2.03

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$597,222

Free Cash Flow

-$597,222

Stock-Based Comp.

$117,500

Balance Sheet

Total Assets

$1M

Total Liabilities

$128,908

Stockholders' Equity

$1M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$763,420	-$1M	+43.0%
Net Income	-$763,420	-$1M	+43.0%